High-density lipoprotein and C-reactive protein, friend and foe in cardiovascular disease

Thesis

Cover

Titlepage

Contents

Chapter 1 C-reactive protein and atherogenesis: from fatty streak to clinical event

Chapter 2 High-density lipoprotein and atherogenesis: from fatty streak to clinical event

Chapter 3 Measurement of subclinical atherosclerosis: beyond risk factor assessment

Chapter 4 A Novel ApoA-I Mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness and premature coronary artery disease

Chapter 5 Restoration of endothelial function by increasing HDL in subjects with isolated low-HDL

Chapter 6 Consequences of cholesteryl ester transfer protein inhibition in patients with familial hypoalphalipoproteinemia

Chapter 7 Activation of inflammation and coagulation after infusion of C-reactive protein in humans

Chapter 7-1 Letters to the Editor: reply to van den Berg, CW and Taylor, KE

Chapter 7-2. Letters to the Editor: In vivo effects of C-reactive protein (CRP)-infusion into humans

Chapter 8 Infusion of C-reactive protein in humans activates circulating leukocytes and increases circulating levels of MMP-9 and MCP-1

Chapter 9 Effects of CRP-infusion on endothelial function and coagulation in normo- and hypercholesterolemic subjects

Chapter 10 Reconstituted apoAI-phosphatidylcholine neutralizes atherothrombotic effects of C-reactive protein in humans

Chapter 11 Summary

Chapter 12 Nederlandse samenvatting

Dankwoord

Cover